Speech-to-speech Voice-cloning Care (SVCC) to Improve ICU-acquired Anxiety for Critically Ill Patients

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorPeking Union Medical College Hospital

About this trial

The goal of this clinical trial is to learn the effect of Speech-to-speech Voice-Cloning Care (SVCC) on improving ICU-acquired anxiety for critically ill patients. The main question it aims to answer is:

* Can the use of participants' loved ones' voices by nurses in communication while providing care lead to better mental health and clinical outcomes?

Researchers will see if the implementation of SVCC can reduce anxiety and depression and improve clinical outcomes.

Participants will:

* Receive the SVCC intervention until the endotracheal tube (ETT) is removed. * Keep a diary of delirium, the duration of mechanical ventilation, and ICU stays.

Eligibility criteria

Qualifiers

Expected mechanical ventilation time > 24 hours;

Expected ICU stay > 72 hours;

Language: Chinese;

Richmond Agitation-Sedation Scale (RAAS) score ≥ -2 points;

Disqualifiers

Severe hearing impairment or worse (Grade 3 or higher according to WHO's Grades of hearing impairment);

Disorders of consciousness or comprehension;

Mental or psychological disorders that are being treated with medication;

Head trauma or surgery resulting in an inability to wear earphones.

Trial design

Treatments tested in this trial

  • Speech-to-speech Voice-Cloning Care (SVCC)

Treatment groups

234 Participants
are divided into 2 treatment groups